The treatment landscape of nonmetastatic castrate resistant prostate cancer: A contemporary perspective

CONCLUSIONS: Thus, nmCRPC is an uncommon disease. Further population-based studies are required to better understand the incidence of nmCRPC.PMID:38555235 | DOI:10.1016/j.urolonc.2024.03.005

Source: Urologic Oncology - March 30, 2024 Category: Urology & Nephrology Authors: Brendan A Yanada David Homewood Brendan H Dias Cindy Ogluszko Niall M Corcoran Source Type: research